Company profile
VisusNano | A drug-eluting intraocular lens revolutionising cataract surgery
VisusNano is a biotechnology start-up company developing a drug-eluting intraocular lens, which has the potential to revolutionise cataract surgery
Reference milestones and recent Companies House filing stream events.
Next confirmation statement due date
Next accounts due date
Last confirmation statement made up date
Last accounts made up date
AA | Transaction MzQzNTM5ODcyNmFkaXF6a2N4
Published 12 Sep 2024 10:53
Company registered at Companies House
1 Jun 2024 to 31 May 2026
VisusNano is a medtech start-up company that is developing a drug-eluting intraocular lens implant, for use in patients undergoing cataract surgery. By improving patient outcomes, removing the need for eye drops after surgery, our technology has the potential to revolutionise cataract surgery and glaucoma management. Cataract, defined as opacification of ...
1 Apr 2022 to 31 Oct 2024
VisusNano is a medtech start-up company that is developing a drug-eluting intraocular lens implant, for use in patients undergoing cataract surgery. By improving patient outcomes, removing the need for eye drops after surgery, our technology has the potential to revolutionise cataract surgery. Cataract, defined as opacification of the lens within the eye,...
1 Jun 2020 to 30 Nov 2020
no public description
1 May 2020 to 31 Jan 2022
VisusNano is a medtech start-up company that is developing a drug-eluting intraocular lens, for use in patients undergoing cataract surgery. By improving patient outcomes, removing the need for eye drops after surgery, our technology has the potential to revolutionise cataract surgery in both the human and veterinary markets. Cataract, defined as opacific...
